GMUI Stock UPDATES Standard Oil Co USA (GMUI) 0.3600 09/22/2014

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

MAAS Expands into Healthcare and Wellness Maase Inc. (NASDAQ: MAAS) recently announced a significant expansion into the healthcare and wellness sector following its acquisition of Carve Group Ltd. This strategic move signifies MAAS's commitment to innovate within the traditional wellness product landscape by integrating advanced biotechnology. The acquisition is more than...

Metavesco Celebrates Collaboration with ADHC In a significant development, Metavesco, Inc. (NASDAQ: MVCO) recently expressed excitement over American Diversified Holdings Corporation (NASDAQ: ADHC) announcing their Digital Asset Treasury (DAT) purchase of OTCfi tokens. This partnership is seen as a positive move towards enhancing the visibility and growth of the...

Understanding Short Interest Trends in Discover Financial Discover Financial's stock ticker, DFS, has recently experienced an increase in its short interest, rising to 10.94% since the last report. The total number of shares sold short now stands at 3.11 million, equating to 1.42% of the available shares for trading. If we consider the current trading volume, it would...

Immunic Completes Enrollment in Phase 3 Trials Immunic, Inc. (NASDAQ: IMUX), a pioneering biotechnology firm, recently reached a significant milestone by completing enrollment for its Phase 3 ENSURE trials, which focus on its lead drug, vidofludimus calcium. These trials target patients living with relapsing multiple sclerosis (RMS) and aim to evaluate the drug's...

Rising Trend of Ergonomic Posture Wear The growing trend of ergonomic apparel highlights the importance of posture-related health concerns. As people spend more time seated and engaged with screens, discomfort is becoming increasingly common. A recent review has brought attention to this phenomenon, shedding light on how ergonomic clothing can play a pivotal role in...